Market Signal Briefing

METAIRIE, La.--(BUSINESS WIRE)--Biloxi Marsh Lands Corporation Announces Unaudited Results for the Second and Third Quarters of 2025.

SAN FRANCISCO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman reminds investors that the deadline to move the Court for appointment as lead plaintiff in the securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP) is January 5, 2026.

The lawsuit alleges that Inspire Medical and its executives misled investors by providing assurances of “operational readiness” for the Inspire V device launch, while concealing critical failures in billing software and training that made a successful rollout impossible. The revelation of these failures forced an 80% cut to EPS guidance and caused the stock to crash over 32%.

“Our investigation centers on the purported disconnect between management’s claims of being ‘ready to throw the switch’ for the Inspire V launch and the alleged undisclosed operational reality,” said Reed Kathrein, the Hagens Berman partner leading the litigation. “We are specifically scrutinizing when executives knew that the software updates for Medicare claims processing had failed—effectively blocking reimbursement—and whether they concealed the inventory glut of the older Inspire IV device to maintain an artificial stock price. We urge investors in Inspire who suffered significant losses to contact the firm now to discuss their rights.”

Legal Analysis: The "Operational Readiness" Disclosure Gap

The complaint details the alleged material misstatements regarding the Company’s preparation for its most important product cycle. The firm is examining the claimed undisclosed operational hurdles that allegedly contradicted public assurances:

Operational Failure Allegation & Disclosure Key Legal Issues     Billing & Reimbursement Management allegedly claimed policies were updated for prompt payment, but allegedly concealed that software updates for Medicare claims did not take effect until July 1, 2025. Whether INSP should have disclosed that centers could not bill for procedures, stalling adoption.     Undisclosed Sales Practice Allegedly concealed that customers held significant surplus inventory of the older Inspire IV device, stifling demand for the new product. Whether INSP should have disclosed alleged channel inventory headwinds.     The Financial Impact (Aug. 4, 2025) Stock fell $42.04 per share (32%) after the Company admitted to an "elongated timeframe" and slashed 2025 EPS guidance by over 80%. Whether investors are entitled to damages resulting from the defendants’ alleged wrongful acts and omissions.
The lawsuit covers investors who purchased Inspire Medical securities between August 6, 2024, and August 4, 2025.

Next Steps: Contact Partner Reed Kathrein Today

Hagens Berman has a proven track record, securing over $325 billion in settlements for investors and consumers.

Mr. Kathrein is actively advising investors who purchased INSP shares during the Class Period and suffered significant losses due to the alleged undisclosed Inspire V launch failures.

The Lead Plaintiff Deadline is January 5, 2026.

TO SUBMIT YOUR INSPIRE MEDICAL (INSP) STOCK LOSSES NOW, PLEASE USE THE SECURE FORM BELOW:

Submit your Inspire Medical (INSP) Stock Losses NowContact: Reed Kathrein at 844-916-0895 or email [email protected]
If you’d like more information and answers to frequently asked questions about the Inspire case and our investigation, read more »

Whistleblowers: Persons with non-public information regarding Inspire should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Contact:
Reed Kathrein, 844-916-0895

SAN FRANCISCO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman reminds investors that the deadline to move the Court for appointment as lead plaintiff in the securities class action lawsuit against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is January 9, 2026.

The lawsuit follows a series of regulatory setbacks and steep stock declines, including a 21% drop after the final regulatory news. The complaint alleges that Telix and its executives materially overstated the developmental progress of its therapeutic candidates (specifically TLX591 and TLX592) and misrepresented the reliability and regulatory compliance of its third-party supply chain and manufacturing partners.

“The complaint alleges that management’s claims of ‘great progress’ and ‘truly global manufacturing capability’ were directly at odds with the reality of regulatory scrutiny,” said Reed Kathrein, the Hagens Berman partner leading the litigation. “We are specifically investigating the documented notices of deficiency (Form 483) issued to two third-party partners which led to the FDA’s Complete Response Letter (CRL). These failures were material and allegedly concealed from investors. The firm urges Telix investors who suffered substantial losses to contact the firm now to discuss their rights.”

Legal Analysis: Dual Regulatory Failures & Supply Chain Deception

The complaint highlights two distinct regulatory events that allegedly corrected the market’s misperception of Telix’s business, operation and prospects:

Alleged Regulatory FailureAlleged Disclosure Event & Stock ImpactKey Legal IssuesSEC InvestigationOn July 22, 2025, Telix revealed an SEC Subpoena relating to disclosures on the development of its prostate cancer therapeutic candidates (TLX591/TLX592).Whether TLX made misleading disclosures on drug development progress.FDA Complete Response Letter (CRL)On August 28, 2025, the FDA rejected the Zircaix (TLX250-CDx) application, citing deficiencies in Chemistry, Manufacturing, and Controls (CMC) and documented Form 483 deficiencies at third-party manufacturers.Whether the company concealed foundational weaknesses in the third-party supply chain and manufacturing processes.Total Stock DropTelix ADSs fell sharply following these regulatory revelations.Whether investors who purchased TLX ADSs during the Class Period (Feb. 21, 2025 – Aug. 28, 2025) are entitled to damages.
Next Steps: Contact Partner Reed Kathrein Today

Hagens Berman is one of the nation’s top plaintiff litigation firms, securing substantial recoveries for investors.

Mr. Kathrein and the firm’s investor fraud attorneys are actively advising investors who purchased TLX ADSs during the Class Period and suffered substantial losses due to the undisclosed supply chain and therapeutic progress flaws.

The Lead Plaintiff Deadline is January 9, 2026.

TO SUBMIT YOUR TELIX (TLX) LOSSES NOW, PLEASE USE THE SECURE FORM BELOW:

Submit Your Telix (TLX) Class Period Investment Losses NowContact: Reed Kathrein at 844-916-0895 or email [email protected] If you’d like more information and answers to frequently asked questions about the Telix case and our investigation, read more »

Whistleblowers: Persons with non-public information regarding Telix should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:
Reed Kathrein, 844-916-0895

Matt Belloni, Puck founding partner, joins 'Power Lunch' to discuss Netflix's proposed bid for Warner Bros. Discovery, what will happen with CNN and much more.

SAN FRANCISCO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Investor rights law firm Hagens Berman reminds investors of the January 12, 2026, deadline to move the Court for appointment as lead plaintiff in the securities fraud class action lawsuit filed against Stride, Inc. (NYSE: LRN). The lawsuit alleges that Stride, one of the nation's largest providers of online educational services, misled investors about its operational health and compliance, resulting in a stock crash of over 54% following damaging disclosures.

“The claims against Stride are particularly troubling, alleging that the company inflated enrollment figures by retaining ‘ghost students’ and then compounded the deception with a disastrous platform upgrade that management was aware of,” said Reed Kathrein, the Hagens Berman partner leading the investigation. “We are actively scrutinizing whether executives knew of these undisclosed facts and urge investors who suffered substantial losses to contact Hagens Berman now to discuss their rights.”

Key Facts for LRN Investors:

Class Period: October 22, 2024 – October 28, 2025, inclusive.Lead Plaintiff Deadline: January 12, 2026.Case Status: Securities Class Action pending in the U.S. District Court for the Eastern District of Virginia.Core Allegations: The complaint alleges Stride made materially false and misleading statements regarding its business by: Inflating Enrollment: Retaining "ghost students" on enrollees who never officially started or were absent for extended periods.Ignoring Compliance: Cutting costs by increasing student-to-teacher ratios far beyond required limits and ignoring mandated special education services.Undisclosed Operational Failures: Concealing major technical issues from an "upgraded platform" that led to "poor customer experience," high withdrawal rates, and a devastating loss of 10,000 to 15,000 enrollments. What Happened and Why it Matters:

The lawsuit stems from two distinct disclosures that revealed the Company’s true condition and triggered massive stock drops:

September 14, 2025: A public report surfaced detailing a lawsuit by a school district (Gallup-McKinley), alleging fraud and deceptive practices, including the use of "ghost students" to artificially inflate enrollment and profits. Stride’s stock plunged 11% on this news.October 28, 2025: Stride announced its Q1 fiscal 2026 results, revealing a severe operational issue due to a failed platform upgrade. The poor customer experience and system disruption caused significant enrollment losses. Stride’s stock subsequently crashed over 54% in a single day. Hagens Berman is investigating whether Stride’s management intentionally misled investors about the stability of its enrollment figures and the severity of its operational and compliance failures to artificially inflate its stock price.

Next Steps for Investors:

If you purchased Stride, Inc. securities during the Class Period (October 22, 2024 – October 28, 2025) and suffered substantial losses, you may be eligible to serve as Lead Plaintiff.

The deadline to file your motion for Lead Plaintiff is January 12, 2026.

TO SUBMIT YOUR LOSSES NOW OR FOR A CONFIDENTIAL CONSULTATION:

Visit: www.hbsslaw.com/investor-fraud/lrn
Contact the Firm Now: [email protected] | 844-916-0895

If you’d like more information and answers to frequently asked questions about the Stride case and our investigation, read more.

Whistleblowers: Persons with non-public information regarding Stride should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:
Reed Kathrein, 844-916-0895

HomeStock IdeasLong IdeasIndustrial 

SummaryUnion Pacific is rated Hold with a $253 price target, implying 10% upside but benchmark-like returns.UNP operates at premium margins and maintains a shareholder-friendly capital allocation via buybacks and dividends but faces revenue headwinds and high leverage.Recent FQ3 2025 results showed modest top-line growth (2.5%) and strong EPS growth (12%), but revenue missed consensus and clouds the outlook.At a 20x forward P/E and elevated leverage, UNP appears fairly valued, with limited catalysts for outperformance absent renewed top-line acceleration. Photofex-AT/iStock via Getty Images

Union Pacific (UNP) is an American, market-leading industrial heavyweight operating in the ground transportation space. UNP offers railroad and freight transportation services, a steady, predictable, and reliable business, presenting a defensive approach. The company also offers a

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Meta plans to direct its investments to focus on wearables like its augmented reality glasses but does not plan to abandon building the metaverse.

Flex Ltd. (FLEX) UBS Global Technology and AI Conference 2025 December 4, 2025 11:35 AM EST

Company Participants

Michael Hartung - President & Chief Commercial Officer
Kevin Krumm

Conference Call Participants

David Vogt - UBS Investment Bank, Research Division

Presentation

David Vogt
UBS Investment Bank, Research Division

Great. Good morning, everyone. Thank you again for joining the UBS Technology Conference. I'm David Vogt. I'm the UBS hardware networking analyst here, and we're excited to have with us today Flex. I believe Flex was here -- yes, Michael we were here last year. So with the company, we have on the far left or far right from your perspective, Kevin Krumm, Chief Financial Officer; Michael Hartung, Chief Commercial Officer. We're excited to have you.

Question-and-Answer Session

David Vogt
UBS Investment Bank, Research Division

So what I thought we would do in the 30 minutes is kind of maybe touch on kind of the big picture topics of the business. We've gotten a lot of questions in the last month or so about your business, what's going on in the world of EMS and supply chain. So maybe if we can just start with, if we look at kind of the big picture drivers of your business, we can start with maybe agility first. kind of how should investors think about longer term, the big drivers in agility and then we can jump into reliability after.

Michael Hartung
President & Chief Commercial Officer

Okay. Great. So if we're going to talk about the long-term drivers, maybe we start with what the secular trends are, what the megatrends are, how they flow through to the different businesses that we have. And so the first one is going to be really obvious. The first driver of demand for us is anything related to AI or data center. We expect that to continue

Recommended For You

KUALA LUMPUR, Malaysia, Dec. 04, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced that it has approved the spin-off of its capital markets advisory subsidiary, V Capital Consulting Group (“VCCG”), at a valuation of US$168 million. Following the listing, VCI Global will retain a 30% equity interest in VCCG, supporting the Company’s transition toward a more focused, technology-driven business model and a strengthened balance sheet.

The transaction marks the first execution of VCI Global’s newly introduced dual-track IPO strategy, an initiative designed to unlock subsidiary value, improve capital efficiency, and create clearer operating verticals aligned with long-term growth priorities.

Dual-Track IPO Strategy: Building Distinct Pathways for Scalable Growth

Track 1: 100% Pre-Money Carve-Out IPOs (Core Technology Divisions)

V Gallant Limited (“V Gallant”): provides Enterprise Data and AI solutions, including AI Infrastructure, AI Analytics Platform, AI Security & Consulting Services, Cybersecurity & ISO Certification Consulting to support digital transformation in emerging marketsSmart Bridge Technologies Limited (“Smart Bridge”): develops stablecoin infrastructure and provides digital asset and real-world asset (RWA) advisory solutions for institutional and enterprise adoption Track 2: 30% Retained Spin-Off IPOs (Mature Portfolio Division)

V Capital Consulting Group Limited (“VCCG”): provides listing (IPO) consultancy and business strategy advisory, leveraging regional expertise to guide high-growth companies and optimize capital structuresVC Real Estate Limited (“VCRE”): property investment and development, focusing on commercial and residential assets across Southeast AsiaVCI Energy Limited (“VCI Energy”): develops renewable energy and infrastructure projects, with a focus on clean energy generation and storage, sovereign energy frameworks, and strategic partnerships across Asia
This dual-track structure enables VCI Global to progressively surface the intrinsic value of its subsidiaries while preserving long-term strategic upside across key portfolio companies.

The spin-off of VCCG converts internal business value into market-recognized equity assets, enhancing balance sheet flexibility without shareholder dilution. It also enables VCCG to pursue its own capital-raising initiatives and listing objectives independently, providing greater operational autonomy. At the Group level, the spin-off reinforces VCI Global’s strategy to allocate resources toward its highest-growth technology verticals, including AI, GPU infrastructure, cybersecurity, and digital asset infrastructure.

“The spin-off of VCCG at US$168 million valuation represents an important milestone as we align our structure with the Group’s long-term strategic direction. Our dual-track IPO strategy is designed to unlock value systematically while ensuring that VCI Global focuses on our highest-growth technology verticals. VCCG’s transition onto an independent listing pathway underscores our commitment to capital discipline, stronger governance, and long-term shareholder value creation,” said Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global.

About V Capital Consulting Group Limited

V Capital Consulting Group, a spin-off and subsidiary of VCI Global (NASDAQ:VCIG), is a consulting firm specializing in capital markets advisory services across pre-IPO, IPO, and post-IPO phases, as well as merger and acquisition advisory services. Our team of experienced consultants is recognized for its in-depth knowledge and proven track record of delivering impactful results.

With a core team of experts in corporate finance, capital markets, and legal advisory, we empower clients to navigate complex market landscapes, anticipate challenges, and seize business opportunities.

To date, VCCG has successfully assisted notable companies in securing Nasdaq listings, including Founder Group Limited, YY Group Holding Limited, and others.

About VCI Global Limited

VCI Global Limited is a cross-sector platform builder at the forefront of technology and financial architecture. The Company focuses on developing and scaling platforms across artificial intelligence, encrypted data infrastructure, digital treasury systems, and next-generation capital markets solutions.

By integrating technology innovation with financial ecosystems, VCI Global enables enterprises, governments, and institutions to capture opportunities in the evolving digital economy. The Company’s strategy is centered on building scalable platforms that deliver resilience, efficiency, and long-term value across multiple high-growth sectors.

For more information on the Company, please log on to https://v-capital.co/.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. These forward-looking statements are based only on our current beliefs, expectations, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Therefore, you should not rely on any of these forward-looking statements. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including without limitation, the Company’s ability to achieve profitable operations, customer acceptance of new products, the effects of the spread of coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company’s products and the Company’s customers’ economic condition, the impact of competitive products and pricing, successfully managing and, general economic conditions and other risk factors detailed in the Company’s filings with the United States Securities and Exchange Commission (“SEC”). The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update the forward-looking statements in this release, except in accordance with applicable law.

CONTACT INFORMATION:

For media queries, please contact:

VCI GLOBAL LIMITED
[email protected]

December 04, 2025 15:30 ET

 | Source:

Aimfinity Investment Corp. I

Wilmington, Delaware, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (OTC: AIMTF) (the “Company”), a blank check company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from November 28, 2025 to December 28, 2025, on November 28, 2025, I-Fa Chang, manager of the sponsor of the Company, has deposited into its trust account (the “Trust Account”) an aggregate of $500 (the “Monthly Extension Payment”).

Pursuant to the Company’s amended & restated memorandum and articles of association effective at this time (the “Current Charter”), the Company may extend on a monthly basis from October 28, 2025 until July 28, 2026 or such an earlier date as may be determined by its board to complete a business combination by depositing the Monthly Extension Payment for each month into the Trust Account. This is the second of nine monthly extensions sought under the Current Charter of the Company.  

About Aimfinity Investment Corp. I

Aimfinity Investment Corp. I is a special purpose acquisition company (SPAC) focused on merging with high-growth potential businesses and facilitating their entry into the capital markets.

Additional Information and Where to Find It

As previously disclosed, on October 13, 2023, AIMA entered into that certain Agreement and Plan of Merger (as may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and between AIMA, Docter, Aimfinity Investment Merger Sub I, a Cayman Islands exempted company and wholly-owned subsidiary of AIMA (“Purchaser”), and Aimfinity Investment Merger Sub II, Inc., a Delaware corporation and wholly-owned subsidiary of Purchaser (“Merger Sub”), pursuant to which AIMA is proposing to enter into a business combination with Docter involving an reincorporation merger and an acquisition merger. This press release does not contain all the information that should be considered concerning the proposed business combination and is not intended to form the basis of any investment decision or any other decision in respect of the business combination. AIMA’s shareholders and other interested persons are advised to read, when available, the proxy statement/prospectus and the amendments thereto and other documents filed in connection with the proposed business combination, as these materials will contain important information about AIMA, Purchaser or Docter, and the proposed business combination. The proxy statement/prospectus and other relevant materials for the proposed business combination have been mailed to shareholders of AIMA as of the record date of February 25, 2025, established for voting on the proposed business combination. Such shareholders will also be able to obtain copies of the proxy statement/prospectus and other documents filed with the SEC, without charge, once available, at the SEC’s website at www.sec.gov, or by directing a request to AIMA’s principal office at 221 W 9th St, PMB 235 Wilmington, Delaware 19801.

Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the Securities Act of 1933, as amended (the “Securities Act”) and the Securities Exchange Act of 1934, as amended. Statements that are not historical facts, including statements about the proposed transactions described herein, and the parties’ perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transaction, including the anticipated initial enterprise value and post-closing equity value, the benefits of the proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, and the expected timing of the proposed transactions. The words “expect,” “believe,” “estimate,” “intend,” “plan” and similar expressions indicate forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to various risks and uncertainties, assumptions (including assumptions about general economic, market, industry and operational factors), known or unknown, which could cause the actual results to vary materially from those indicated or anticipated.
  
Such risks and uncertainties include, but are not limited to: (i) risks related to the expected timing and likelihood of completion of the proposed business combination, including the risk that the transaction may not close due to one or more closing conditions to the transaction not being satisfied or waived, such as regulatory approvals not being obtained, on a timely basis or otherwise, or that a governmental entity prohibited, delayed or refused to grant approval for the consummation of the transaction or required certain conditions, limitations or restrictions in connection with such approvals; (ii) risks related to the ability of AIMA and Docter to successfully integrate the businesses; (iii) the occurrence of any event, change or other circumstances that could give rise to the termination of the applicable transaction agreements; (iv) the risk that there may be a material adverse change with respect to the financial position, performance, operations or prospects of AIMA or Docter; (v) risks related to disruption of management time from ongoing business operations due to the proposed transaction; (vi) the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of AIMA’s securities; (vii) the risk that the proposed transaction and its announcement could have an adverse effect on the ability of Docter to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on their operating results and businesses generally; (viii) risks relating to the medical device industry, including but not limited to governmental regulatory and enforcement changes, market competitions, competitive product and pricing activity; and (ix) risks relating to the combined company’s ability to enhance its products and services, execute its business strategy, expand its customer base and maintain stable relationship with its business partners.

A further list and description of risks and uncertainties can be found in the prospectus filed with the Securities and Exchange Commission (the “SEC”) on April 26, 2022 relating to AIMA’s initial public offering (File No. 333-263874), the annual report of AIMA on Form 10-K for the fiscal year ended on December 31, 2024, filed with the SEC on April 15, 2025, and in the final prospectus/proxy statement filed with the SEC on March 6, 2025 relating to the proposed transactions (File No. 333-284658) (the “Final Prospectus”), and other documents that the parties may file or furnish with the SEC, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and AIMA, Docter, and their subsidiaries or affiliates undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

Additional Information and Where to Find It

In connection with the proposed transactions described herein, Purchaser filed the Final Prospectus with the SEC on March 6, 2025. The proxy statement and a proxy card has been mailed to AIMA’s shareholders of record as of February 25, 2025. Shareholders of AIMA will also be able to obtain a copy of the Final Prospectus without charge from AIMA. The Final Prospectus may also be obtained without charge at the SEC’s website at www.sec.gov. INVESTORS AND SECURITY HOLDERS OF AIMA ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE PROPOSED TRANSACTIONS THAT AIMA WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT AIMA, DOCTER AND THE PROPOSED TRANSACTIONS. 

Participants in the Solicitation

AIMA, Docter, and their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of AIMA’s shareholders in connection with the proposed transactions described herein. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of AIMA’s shareholders in connection with the proposed business combination is set forth in the Final Prospectus.

No Offer or Solicitation

This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of any potential transaction and does not constitute an offer to sell or a solicitation of an offer to buy any securities of AIMA, Purchaser or Docter, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom.

Aimfinity Investment Corp. I
I-Fa Chang
Chief Executive Officer
221 W 9th St, PMB 235
Wilmington, Delaware 19801
[email protected]

Customers earning more than $100,000 make up most of Dollar Tree’s new customers.

Dollar Tree CEO Michael Creedon said this week that the chain continues to see a significant boost in traffic with 3 million more households shopping at its stores during the three-month period ending Nov. 1 compared with the same period a year earlier.

Approximately 60% of those new customers were higher-income households – those earning over $100,000 – according to Creedon. About 30% were middle-income households – earning between $60,000 to $100,000 – and the rest were lower-income households, or those earning under $60,000. 

DOLLAR GENERAL SEES INCREASE IN HIGHER-INCOME SHOPPERS LOOKING TO STRETCH THEIR DOLLARS

"Today, we serve an increasingly broad spectrum of shoppers, from core value-focused households to middle- and higher-income shoppers who are making deliberate choices about how and where they spend," Creedon said, adding that the data "demonstrates that Dollar Tree isn't just for tough times or for those with limited resources." 

People walk by a Dollar Tree store in Brooklyn on March 26, 2025, in New York City. (Spencer Platt/Getty Images)

He said higher-income households are trading down to Dollar Tree while lower-income households are relying on the company more than ever as economic pressures force consumers across the board to cut back on discretionary spending.

The average spending for lower-income households grew more than twice as fast in the three-month period as the average spending for higher-income households, underscoring how those households remain "loyal and deeply engaged." 

The chief executive is aiming to create that same loyalty among its newer, higher-income customers, who are earlier in their customer life cycle with the company and spend more during each trip. 

DOLLAR TREE SELLING FAMILY DOLLAR FOR ABOUT $1B

People shop in a Dollar Tree store in Brooklyn on March 26, 2025. ( Spencer Platt/Getty Images)

'While the average per household spend for our higher income customers is currently lower, even given their higher income, larger average basket size and ability to spend more, this is a simple function of trip frequency," Creedon said, adding, "because many of our higher income customers are still early in their relationship with Dollar Tree, their purchase frequency has significant room to grow." 

DOLLAR TREE TO CLOSE AROUND 1K FAMILY DOLLAR STORES

However, this trend of gaining higher earners isn't unique to Dollar Tree. Rather, it’s part of a broader consumer shift driven by higher inflation. 

Customers shop at a Dollar Tree store on Aug. 2, 2022, in Chicago. (Scott Olson/Getty Images / Getty Images)

The elevated cost of essentials like groceries and household items has forced even affluent households to look for ways to stretch their budgets. Many of them have traded down to stores known for their heavy discounting or everyday low-price models. Companies like Dollar Tree, Dollar General, Walmart and Aldi continue to benefit. 

In June, Dollar General said its new customers are shopping more often and spending more per visit compared with new customers last year. They are also allocating more of their spending to discretionary categories. Its CEO, Todd Vasos, told analysts during a June earnings call that these behaviors suggest that the company is continuing to attract higher-income customers who are looking to maximize value.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Ticker Security Last Change Change % DLTR DOLLAR TREE INC. 115.47 +2.56
+2.26%
Walmart has reported on back-to-back earnings calls that its share of high-income shoppers continues to grow. In its latest quarter, which ended on Oct. 31, the company said customers earning over $100,000 accounted for roughly 75% of its share gains.

C3.ai Inc (NYSE:AI) shares rose in early trading on Thursday, after the company on Wednesday reported upbeat fiscal second-quarter results.

• AI shares are advancing steadily. Watch the momentum here.

Here are some key analyst takeaways:

Wedbush analyst Dan Ives reaffirmed an Outperform rating and price target of $20.
Canaccord Genuity analyst Kingsley Crane reiterated a Hold rating and price target of $16.
DA Davidson analyst Lucky Schreiner reaffirmed an Underperform rating and price target of $13.
Needham analyst Mike Cikos maintained a Hold rating on the stock.
Check out other analyst stock ratings.

Wedbush: C3.ai reported total revenue of $75.1 million, missing the midpoint of its guidance range but coming in above consensus of $74.9 million, Ives said in a note. Under the leadership of new CEO Stephen Ehikian, the company is looking to "turn the ship around following its disastrous execution last quarter," he wrote.

There was momentum in C3.ai's federal business in the third quarter, despite the prolonged government shutdown, the analyst stated.

"The company's hyperscaler partnerships remain key," as it jointly closed 24 agreements and expanded Microsoft Corp (NASDAQ:MSFT) deal activity by 146% year-on-year and closed nine agreements and expanding its joint qualified pipeline with Amazon.com Inc's (NASDAQ:AMZN) AWS by 172%, he added.

Canaccord Genuity: C3.ai's performance in the latest quarter marked a sequential improvement, after the previous quarter's 30% contraction in subscription revenues, Crane said. Still, total revenue declined 20% year-on-year and non-GAAP gross margins remained under pressure at 55%, he added.

C3.ai recorded 89% growth in federal bookings, despite the 43-day government shutdown, the analyst stated. "Microsoft, AWS, McKinsey, Baker Hughes and Booz Allen are playing a larger role in pipeline generation," he further wrote.

DA Davidson: C3.ai reported net new revenue of around $4 million, driven in part by growth of license demonstration revenue from partners, Schreiner said. Subscription revenue declined by 22% year-on-year, representing an improvement from the 30% contraction in the previous quarter, he added.

Management reintroduced the revenue guidance for fiscal 2026, at $289.5-$309.5 million, which implies a 23% decline, the analyst stated. "C3.ai is still playing catch up from last quarter’s large miss but was able to avoid any negative impact from the federal shutdown during the quarter," he further wrote.

Needham: Despite the government shutdown, C3.ai recorded bookings from Federal, Defense and Aerospace, Cikos said. He added that management expects the Federal business to remain "a durable growth engine" due to the government’s initiatives to:

Buy more commercial solutions instead of building them
Drive AI adoption
Reindustrialize efforts such as the Maritime Industrial Base
The company guided to third quarter revenue of $72-$80 million and fiscal 2026 revenue of $289.5-$309.5 million, versus estimates of $75.6 million and $298.7 million, respectively, the analyst stated.

AI Price Action: Shares of C3.ai had risen by 2.33% to $15.36 at the time of publication on Thursday.

Read More:
• C3.ai CEO Stephen Ehikian Admits Fallout From Tom Siebel’s Health Crisis, Sales Reorg Chaos: ‘There’s Work To Be Done…’

Photo: Poetra.RH via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Key Takeaways Pharvaris surged after RAPIDe-3 showed deucrictibant delivering far faster HAE symptom relief than placebo.The study met all primary and secondary endpoints, with most attacks treated by a single deucrictibant dose.PHVS plans to file for approval in 2026, as investors compare results with KALV's recently approved Ekterly.
Shares of Pharvaris (PHVS - Free Report) rose nearly 22% on Wednesday after the company announced positive results from the phase III RAPIDe-3 study evaluating its lead pipeline drug deucrictibant in the hereditary angioedema (HAE) indication.

This study evaluated an immediate-release capsule version of the drug for the on-demand treatment of HAE attacks in adults and adolescents aged 12 years and older.

The RAPIDe-3 study achieved its primary endpoint — patients began experiencing symptom relief within 1.28 hours of taking the drug compared with more than 12 hours with placebo. The study also met all its secondary endpoints, including shorter median time to substantial symptom relief (under 3 hours with deucrictibant compared with more than 12 hours with placebo) and earlier complete symptom resolution (11.95 hours compared with more than 24 hours).

Pharvaris also noted that while 83% of HAE attacks in the RAPIDe-3 study were addressed with just one dose of deucrictibant, more than 93% of the attacks were treated with the drug without the need for any backup treatment.

A rare genetic disease, HAE is marked by severe and potentially fatal swelling of the arms, legs, face and throat.

PHVS to Seek FDA Nod for HAE DrugBased on the above results, Pharvaris intends to submit a regulatory filing for deucrictibant in the first half of 2026. If approved, it will be the second oral on-demand therapy in the market after KalVista Pharmaceuticals’ (KALV - Free Report) Ekterly, which received approval for a similar indication in July.

This sets up a natural comparison between the two therapies. Some investors have highlighted the potential superiority of deucrictibant over KalVista’s Ekterly by comparing the primary endpoint results of the RAPIDe-3 study with those from the late-stage KONFIDENT study, which supported Ekterly’s approval. In this late-stage study, patients treated with the KALV drug began experiencing symptom relief after 1.61-1.79 hours, falling just shy of the numbers posted by Pharvaris. PHVS shares jumped primarily due to this comparison.

Year to date, the stock has soared 53% compared with the industry’s 20% growth.

Image Source: Zacks Investment Research

More on Pharvaris’ DeucrictibantThe company is developing two formulations of deucrictibant — an immediate-release capsule version to enable rapid onset of activity for acute treatment, and an extended-release tablet to allow sustained absorption and efficacy in prophylactic treatment.

Pharvaris is evaluating the extended-release tablet formulation of the drug in the phase III CHAPTER-3 study for the prophylaxis against HAE attacks in adults and adolescents aged 12 years and older. Top-line data from this study is expected in the second half of 2026.

The extended-release tablet version of deucrictibant is also being evaluated in the late-stage CREAATE study for the prophylactic and on-demand treatment of attacks caused due to acquired angioedema with C1-inhibitor deficiency (AAE-C1INH) — a rare condition resembling HAE.

PHVS’ Competition in the HAE SpacePharvaris intends to market deucrictibant as both on-demand and prophylaxis treatment of HAE attacks.

In the on-demand treatment space, if the drug is approved, it will face stiff competition from KalVista’s Ekterly. Therapies like deucrictibant and Ekterly hold an edge over previously approved on-demand treatments like Firazyr and Kalbitor — both marketed by Takeda — as they are administered via injections, which can be challenging for patients in a crisis. The convenience of a tablet, which can be taken at the first signs of an attack, can drive broader adoption and enhance patient compliance.

Concerning the prophylactic treatment space, companies like BioCryst Pharmaceuticals (BCRX - Free Report) and Ionis Pharmaceuticals (IONS - Free Report) market drugs in this segment. While BioCryst’s Orladeyo was approved by the FDA in 2020 as the first oral treatment for HAE attacks in individuals aged 12 years and older, Ionis’ Dawnzera was recently approved for a similar indication in August.

PHVS Zacks RankPharvaris currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Bank of America will begin allowing its wealth advisers to recommend allocations to crypto in client portfolios from next month, the U.S. lending giant said on Thursday, in a landmark moment for the digital assets sector.

TJX Companies Inc (NYSE:TJX) long record of outperforming expectations positions the off-price retailer for further gains as it leans into pricing power, international growth and an expanding store base, according to analysts at Bank of America.

Analysts said TJX’s ability to consistently beat sales and margin forecasts is “rare” in the current retail landscape and should continue to support multiple expansion.

The firm expects the owner of TJ Maxx, Marshalls and HomeGoods to maintain its trend of low- to mid-single-digit comparable sales growth, helped by strong inventory availability and a branded merchandise assortment that continues to attract value-seeking shoppers.

Bank of America highlighted pricing as a new tailwind for margins, particularly at Marmaxx, which includes the TJ Maxx and Marshalls chains in the US. The brokerage models operating margin rising to 12% by fiscal 2028, noting that higher ticket prices could add further upside as tariffs push prices higher across key categories.

TJX spent years lowering prices amid competitive pressures, a period that contributed to margin contraction from fiscal 2015 to 2020, the analysts noted. “The opposite of that could happen now,” they wrote, as industry-wide tariff-driven increases create room for TJX to take price while still offering relative value.

International and HomeGoods divisions also present opportunities for margin improvement, according to the note.

Bank of America said TJX’s long-tenured buying organization remains a competitive advantage, allowing the retailer to secure ample branded inventory even as tariffs disrupt supply chains. The backdrop, it said, is shaping up to be “a highly favorable environment for merchandise availability” heading into the holiday season.

The analysts also pointed to store expansion as a steady contributor to growth. TJX is targeting 7,000 stores across current and planned geographies, up from 5,191 today. New HomeGoods and international locations are expected to account for most of that expansion, resulting in a 2% to 3% annual lift to total sales from new stores.

“We see opportunity for sales growth from trade down and margin expansion from higher prices, international and HomeGoods,” Bank of America wrote.

Bank of America reiterated its “Buy” rating and $168 price objective on TJX stock, which was trading around $150 on Thursday afternoon.

The move against the US giant marks the latest move by the 27-nation EU to rein in Big Tech.

The EU said Thursday it had opened an antitrust probe to determine if the way Meta is rolling out AI features in WhatsApp breaches the bloc's competition rules.

The move against the US giant marks the latest attempt by the 27-nation EU to rein in Big Tech, in the face of strong pushback by the government of US President Donald Trump.

The probe falls under the bloc's antitrust rules rather than its newly reinforced digital laws, which Trump has accused of unfairly targeting American firms—threatening retaliation.

The European Commission said it was concerned that a newly announced Meta policy "may prevent third party AI providers from offering their services through WhatsApp."

WhatsApp pushed back against the claims as "baseless."

But EU competition chief Teresa Ribera said the bloc must "act to prevent dominant digital incumbents from abusing their power to crowd out innovative competitors."

"This is why we are investigating if Meta's new policy might be illegal under competition rules, and whether we should act quickly to prevent any possible irreparable harm to competition in the AI space," Ribera said in a statement.

The EU says the Meta policy announced in October will bar rival AI providers from using a tool in the business version of WhatsApp to reach customers directly.

The restriction applies "when AI is the primary service offered"—as with an AI chatbot or assistant—though firms may still use AI tools for support functions such as customer support.

"As a result of the new policy, competing AI providers may be blocked from reaching their customers through WhatsApp," the commission said.

"On the other hand, Meta's own AI service 'Meta AI' would remain accessible to users on the platform."

WhatsApp rejected the argument that it risked hindering competition.

"The claims are baseless," a spokesperson said. "The emergence of AI chatbots on our Business API puts a strain on our systems that they were not designed to support."

"Even still, the AI space is highly competitive and people have access to the services of their choice in any number of ways, including app stores, search engines, email services, partnership integrations, and operating systems."

Multiple cases
The EU probe covers the European Economic Area, made up of the bloc's 27 states, Iceland, Liechtenstein and Norway—with the exception of Italy, which opened a separate investigation into Meta in July.

The Italian antitrust body has said that by merging Meta AI with WhatsApp the US giant may be imposing the use of its AI services on users and channeling its customer base into the emerging market.

There is no legal deadline for concluding an antitrust investigation.

Meta already faces the risk of heavy fines under the bloc's Digital Services Act (DSA), which regulates content.

One DSA case accuses Meta of failing to grant researchers sufficient access to public data, another focuses on accusations Meta platforms Facebook and Instagram do not provide user-friendly ways to flag illegal content or challenge content-moderation decisions.

EU regulators are also investigating Facebook and Instagram over fears they are not doing enough to combat the addictive nature of their platforms for children.

Meta has separately appealed against a 200-million-euro fine imposed this year under the bloc's Digital Markets Act competition law over its policy asking users to choose between an ad-free subscription and a free, ad-supported service.

© 2025 AFP

Key Takeaways Most Wall Street investors are focused on LLMs.However, the next wave of AI is likely to be robotics. Investors should begin to build their robotics watchlists.
U.S. Inflation is In Line with Historical Readings, Despite Tariff FearsIn the wake of U.S. President Donald Trump’s ‘Liberation Day’ reciprocal tariff rollout in April, stocks plummeted and many investors sold their stocks. In addition to the temporary market spook, the Trump Administration’s tariff policy triggered inflation fears, especially among left-leaning economists and market participants. For instance, in a November 2024 interview, former U.S. Treasury Secretary and famous economist Larry Summers stated that Trump’s economic plans would lead to a “a more inflationary policy by far than what happened under President Biden in 2021.” Recall that in 2022, CPI inflation spiked to 9%, marking the highest inflation rate in 40 years.

Thus far, the expected “3rd wave” of inflation has not occurred. The consumer price index (CPI) is hovering around 3%, right in line with historical norms.

Image Source: US Bureau of Labor Statistics

Nevertheless, the adverse post-COVID inflation still lingers, and many consumers are struggling. Additionally, many analysts believe that there will be a delayed inflationary reaction to President Trump’s tariff policies.

Bessent’s Vision: A 1990s-esque Productivity BoomCurrent U.S. Treasury Secretary Scott Bessent, a Wall Street legend known for helping George Soros to “break the Bank of England” and make a billion dollars in a single day, has a plan to combat inflation and spur economic growth. The U.S. will take a page from the late 1990s ‘productivity boom,’ when interest rates were low, inflation was under control, and innovation was front and center.

Regardless of where one stands on the inflation debate, one thing is certain – the Trump Administration has proven it will do whatever it can to spur AI-driven productivity growth to win the global AI race.

Robotics: The Next Wave of AI GrowthAlready President Trump has appointed the first-ever ‘AI Czar’, removed cumbersome regulations, and unveiled the ‘AI Action Plan,’ a plan focused on accelerating innovation, building AI infrastructure, and leading in international diplomacy and security. Currently, Wall Street investors are infatuated with the first wave of AI: large language models such as ‘ChatGPT’ and ‘Gemini.’

Robotics Stocks to WatchHowever, earlier this week President Trump announced his plan to issue a robotics-specific executive order in 2026. Meanwhile, U.S. Commerce Secretary Howard Lutnick has been meeting with robotics CEOs to help accelerate the industry. Additionally, industry experts such as Advanced Micro Devices (AMD) CEO Lisa Su see ‘physical AI’ as the next long-term growth opportunity. Below are stocks from five key verticals to monitor as the next wave of AI emerges:

Humanoid/Industrial/Automation/Manufacturing Robots:

Tesla ((TSLA - Free Report) ), Honeywell International ((HON - Free Report) ), Teradyne ((TER - Free Report) ), UiPath ((PATH - Free Report) ).

Drone/Defense:

Ondas Holdings ((ONDS - Free Report) ), Unusual Machines ((UMAC - Free Report) )

Delivery/Logistics:

Serve Robotics ((SERV - Free Report) ).

Consumer:

iRobot ((IRBT - Free Report) ).

Robotics Industry:

VanEck Robotics ETF ((IBOT - Free Report) ).

Bottom Line

Policymakers are determined to drive productivity through AI and robotics. Although many investors are hyper-focused on LLMs, they would be wise to shift some attention to the coming robotics revolution.

Zhihan Ma, Bernstein senior analyst, joins 'The Exchange' to discuss the grocery space, what will be a structural challenge in grocery and much more.

Dell CEO Michael Dell explains why he and Susan Dell are giving 25 million American children $250 each to jumpstart an investment account for their futures. The $6.25 billion gift builds on the Invest America initiative, better known as “Trump accounts," created earlier this year as part of President Donald Trump's One Big Beautiful Bill Act.

Baylin Technologies Inc. (BYL:CA) M&A Call December 4, 2025 10:00 AM EST

Company Participants

Leighton Carroll - President, CEO & Director

Presentation

Operator

Are you ready to get going now? All right. Good morning, everyone, and welcome to the Baylin Technologies Kaelus Acquisition Conference Call. Today is Thursday, December 4, and joining us today is CEO, Leighton Carroll. He will present an overview of the acquisition and its rationale, after which he will respond to questions. [Operator Instructions] Before we begin, I would like to remind everyone that certain statements made today may contain forward-looking statements that are subject to known and unknown risks, uncertainties and other factors. For a complete description of the risks and uncertainties facing the company, please refer to the MD&A and other continuous disclosure filings available on the SEDAR website. And with that, I now pass it on to CEO, Leighton Carroll.

Leighton Carroll
President, CEO & Director

All right. Awesome. Thanks, everybody. It has been quite the journey getting here, but we're obviously very excited. We finally were able to do the announcement and can now talk publicly about this. Here we go. So we tend to talk about Baylin in chapters. And Baylin 1.0, a lot of people are familiar with it. But basically, pre-Q3 of 2001, we had 4 business units. And for the -- just the first 6 months of 2021, we were negative $15 million in adjusted EBITDA, $40 million in debt, 15% gross margins. Baylin 2.0 today, I couldn't be prouder of the team and what we've accomplished. We've divested, obviously, the non-core mobile business. We have sustained profitable growth. We really have our growth engine now in the business, and it's doing well. The debt has been cut roughly in half, and we're running around 43% gross margins.

Recommended For You

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

NEW YORK, NY / ACCESS Newswire / December 4, 2025 / There is a single moment that would hit the gold market harder than any interest rate shock, geopolitical headline or mining crisis. It is not a supply disruption. It is not a surge in demand. It is a policy decision. The moment a major bank, sovereign wealth fund or global exchange announces that it will only accept verified gold with persistent molecular identity is the moment the entire gold ecosystem splits in two. That announcement would not be symbolic. It would be seismic. It would turn legacy bullion into a discounted asset class overnight and elevate verified bullion into the only gold that truly counts.

The truth is that this moment is coming whether the industry wants to acknowledge it or not. Banks know their vaults contain bars they cannot fully authenticate. Sovereign funds know part of their reserves were acquired through systems that relied more on trust than science. Insurers know the risk model behind bullion storage is based on documentation that can be forged. The gold market has been operating on a fantasy of infallibility for decades, and the first institution to demand verifiable truth will force the entire world to face reality.

SMX (NASDAQ:SMX) is positioned at the epicenter of that shift. Its molecular identity system turns gold into a material that can prove itself instantly, no matter how many times it has been melted or recast. And it's showing itself at the right time.

One Institutional Mandate Could Change the World

Institutional mandates shape commodities more powerfully than market forces. When a major exchange changes acceptable standards, the entire global system realigns in days, not years. Gold is particularly vulnerable because its current verification system is built on assumptions rather than evidence. If Goldman Sachs, JPMorgan, BlackRock or the Bank of England declares that only gold with embedded identity will qualify for trade, collateralization or reserve holdings, every bar lacking molecular proof becomes suspect instantly.

This is the beginning of a two-tier gold market. Verified gold becomes the premium tier, carrying higher prices, faster liquidity, and smoother cross-border movement. Unverified gold becomes the secondary tier, trading at discounts because no one can fully trust its origin, purity or legality. The spread between the two groups widens as institutions flee uncertainty. Once this dynamic begins, there is no going back. The market will never again value anonymous bullion the way it values verifiable bullion.

SMX is the force that enables the premium tier to exist. By embedding molecular identity inside the metal itself, the company gives institutions what they have never had: a forensic level of certainty that survives melting, splitting, and reuse. One scan reveals the truth. And in the world of institutional gold, truth is value.

Why Institutions Will Be Forced to Make the Call

The pressure building behind the scenes is relentless. Regulators are tightening anti-money-laundering rules. Sanctions agencies are tracking illicit gold flows with unprecedented scrutiny. Exchanges are reevaluating historical bars in their vaults. Insurers are rewriting policies to reflect authentication risk. Sovereign funds are under political pressure to ensure their reserves are clean. No institution wants to be the first to declare that legacy bullion is not fully trustworthy. But no institution wants to be the last to admit it either.

Eventually, one major player will break the silence. It will choose verified gold because the downside of staying with an unverifiable supply has become too large. The reputational risk is too high. The compliance burden is too heavy. The financial exposure is too opaque. And once that first domino falls, every other major institution will have to follow or risk holding assets the market no longer values equally.

SMX's balance sheet helps position it to meet this demand at the exact moment the call is made. It is no longer a startup pushing innovation uphill. It is a verification backbone with the capital to deploy across continents.

The Global Gold Standard of the Future Will Be Molecular

For decades, analysts predicted the world might return to a monetary gold standard. They missed the real revolution. The next gold standard will not be about currency. It will be about identity. Gold that can prove its origin, its purity, and its legality will rule global trade. Gold that cannot will trade in a shrinking, risk-ridden ecosystem that investors and governments increasingly avoid.

SMX is building that future. Its technology turns bullion into a self-authenticating asset and transforms the entire gold market into a system governed by evidence rather than assumption. The day a major institution demands verified gold is the day the global metals market resets. When that moment arrives, the only gold that matters will be the gold that can prove itself.

And SMX will be the company enabling that new language.

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements

The information in this press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "intends," "may," "will," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company's fight against abusive and possibly illegal trading tactics against the Company's stock; successful launch and implementation of SMX's joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in SMX's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX's ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX's ability to successfully and efficiently integrate future expansion plans and opportunities; SMX's ability to grow its business in a cost-effective manner; SMX's product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX's business model; developments and projections relating to SMX's competitors and industry; and SMX's approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company's shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX's business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX's products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX's filings from time to time with the Securities and Exchange Commission.

Contact: [email protected]

SOURCE: SMX (Security Matters) Public Limited

Kitco News

The Leading News Source in Precious Metals

Kitco NEWS has a diverse team of journalists reporting on the economy, stock markets, commodities, cryptocurrencies, mining and metals with accuracy and objectivity. Our goal is to help people make informed market decisions through in-depth reporting, daily market roundups, interviews with prominent industry figures, comprehensive coverage (often exclusive) of important industry events and analyses of market-affecting developments.

Key Takeaways AWK advances its ASR program to store excess winter storm water for future dry-season use.The ASR initiative offers a cost-effective way to avoid evaporation losses and support emergency supplies.AWK continues to upgrade its existing infrastructure and plans to invest up to $48B in the next 10 years.
American Water Works Company’s (AWK - Free Report) unit, California American Water, has proactively prepared for the Aquifer Storage and Recovery (“ASR”) Program to have provision for an ample water supply when the need arises.

California American Water, along with Monterey Peninsula Water Management District, decided to capture and treat excess rainwater during winter storms when the flow levels of the Carmel River consistently exceeded 40 cubic feet per second. The excess water will be stored in the seaside basin for future use. This water reserve will ensure a more reliable water supply during the dry months.

What is the Need for an ASR Program?ASR Program is a water resource management technique; the main purpose of this program is to store water underground when the water supply is abundant for future usage.

California American Water will gain from the ASR Program because this program is a cost-effective alternative to large surface projects, as it avoids evaporation during dry seasons and can supply water during emergency situations.

This ASR program will ensure a reliable water supply, help with customer retention and increase the customer base, as the company can smoothly meet the rising demand for water.

American Water Works Focused on Infrastructure UpgradesThe U.S. water and wastewater infrastructure is deteriorating, with water main breaks occurring every few minutes, according to the American Society of Civil Engineers. The pipeline breaks result in wastage of potable water and also increase the chances of water contamination.

American Water Works continues to make systematic investments to upgrade its infrastructure. AWK plans to invest $3.7 billion in 2026. In terms of its long-term capital expenditure plan, the company expects to invest $19-$20 billion during the period of 2026-2030 and $46-$48 billion during the period of 2026-2035.

Water Supply Industry Needs Huge InvestmentsThe Environmental Protection Agency estimates that $1.25 trillion in investments will be needed over the next 20 years to maintain and upgrade drinking water, wastewater and stormwater systems.

The regulated water utilities are making investments to upgrade and maintain infrastructure. Apart from American Water Works, other water utilities like Essential Utilities (WTRG - Free Report) and California Water Service Group (CWT - Free Report) , among others, are also making investments to upgrade aging infrastructure.

Essential Utilities’ long-term plan is to invest $7.8 billion from 2025 to 2029 to rehabilitate and strengthen its water and natural gas pipeline systems. WTRG is able to reduce regulatory lag and facilitate growth through strategic acquisitions.

California Water Service Group plans to invest between $450.0 million and $550.0 million in 2025 to further strengthen its existing operations. CWT also stores water in the underground water aquifers, and its management believes that the water already stored in these aquifers is adequate to meet demand in 2025 and thereafter.

Price Movement of AWKIn the past three months, AWK’s shares have underperformed the industry it belongs to.

Image Source: Zacks Investment Research

Zacks Rank & A Key PickAmerican Water Works Company currently carries a Zacks Rank #3 (Hold).